Benjamin Johnson

NPI: 1518339951
Total Payments
$8,880
2024 Payments
$1,469
Companies
27
Transactions
282
Medicare Patients
2,369
Medicare Billing
$185,799

Payment Breakdown by Category

Food & Beverage$5,171 (58.2%)
Other$2,452 (27.6%)
Travel$1,146 (12.9%)
Education$110.69 (1.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $5,171 275 58.2%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,452 1 27.6%
Travel and Lodging $1,146 4 12.9%
Education $110.69 2 1.2%

Top Paying Companies

Company Total Records Latest Year
Medtronic, Inc. $5,359 60 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $718.58 38 $0 (2024)
Novartis Pharmaceuticals Corporation $566.54 54 $0 (2024)
Janssen Pharmaceuticals, Inc $315.29 30 $0 (2024)
PFIZER INC. $308.71 21 $0 (2024)
ABIOMED $200.26 5 $0 (2024)
Merck Sharp & Dohme LLC $192.30 12 $0 (2024)
Kiniksa Pharmaceuticals International, plc $159.90 8 $0 (2024)
Amgen Inc. $159.50 11 $0 (2024)
Actelion Pharmaceuticals US, Inc. $153.82 6 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,469 85 Medtronic, Inc. ($379.36)
2023 $4,930 59 Medtronic, Inc. ($4,266)
2022 $1,548 85 Medtronic, Inc. ($545.92)
2021 $931.92 53 Boehringer Ingelheim Pharmaceuticals, Inc. ($172.19)

All Payment Transactions

282 individual payment records from CMS Open Payments — Page 1 of 12

Date Company Product Nature Form Amount Type
12/19/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $14.14 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
12/09/2024 Actelion Pharmaceuticals US, Inc. OPSUMIT (Drug) Food and Beverage In-kind items and services $12.87 General
Category: Cardiology
12/06/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $27.99 General
Category: Cardiology/Vascular Diseases
12/05/2024 PFIZER INC. VYNDAQEL (Drug) Food and Beverage In-kind items and services $15.21 General
Category: CARDIOVASCULAR
12/03/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $16.67 General
Category: DIABETES
11/19/2024 Kiniksa Pharmaceuticals International, plc Arcalyst (Drug) Food and Beverage In-kind items and services $16.83 General
Category: Not Applicable
11/15/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $27.63 General
Category: Cardio-renal
11/14/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $18.30 General
Category: DIABETES
11/14/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $4.49 General
Category: Cardiology/Vascular Diseases
10/29/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $4.89 General
Category: Cardiology/Vascular Diseases
10/25/2024 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $13.11 General
Category: Cardiovascular
10/22/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $18.45 General
Category: DIABETES
10/21/2024 AstraZeneca Pharmaceuticals LP WAINUA (Drug) Food and Beverage In-kind items and services $17.98 General
Category: Cardiovascular and Metabolism
10/17/2024 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $13.76 General
Category: CARDIOVASCULAR
10/09/2024 PFIZER INC. ELIQUIS (Drug), NURTEC ODT Food and Beverage In-kind items and services $18.60 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/04/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $11.02 General
Category: Cardiology/Vascular Diseases
10/02/2024 Daiichi Sankyo Inc. INJECTAFER (Drug) Food and Beverage In-kind items and services $16.00 General
Category: Iron Deficiency Anemia
09/26/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $5.11 General
Category: Cardiology/Vascular Diseases
09/26/2024 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $0.89 General
Category: Cardiology/Vascular Diseases
09/24/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $10.52 General
Category: Cardiovascular & Metabolism
09/19/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $29.76 General
Category: Cardio-renal
09/13/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $17.08 General
Category: DIABETES
09/09/2024 Actelion Pharmaceuticals US, Inc. OPSUMIT (Drug) Food and Beverage In-kind items and services $11.11 General
Category: Cardiology
08/26/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $10.06 General
Category: Cardiology/Vascular Diseases
08/16/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $14.67 General
Category: Cardiovascular and Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 611 732 $112,625 $49,253
2022 6 574 677 $112,665 $48,806
2021 7 593 708 $107,833 $48,089
2020 9 591 703 $101,625 $39,651
Total Patients
2,369
Total Services
2,820
Medicare Billing
$185,799
Procedure Codes
29

All Medicare Procedures & Services

29 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 294 337 $58,975 $25,724 43.6%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 104 165 $18,150 $8,533 47.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 105 105 $11,550 $5,411 46.8%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 47 62 $9,610 $4,595 47.8%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 27 27 $8,640 $2,887 33.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 16 16 $4,400 $1,444 32.8%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 18 20 $1,300 $659.40 50.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 270 312 $54,600 $24,471 44.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 127 134 $14,740 $6,665 45.2%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 50 50 $16,000 $6,318 39.5%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 83 129 $14,190 $5,971 42.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 30 35 $10,500 $4,230 40.3%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 14 17 $2,635 $1,152 43.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 193 209 $36,575 $17,220 47.1%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 143 221 $24,203 $10,452 43.2%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 58 60 $19,200 $7,791 40.6%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 127 132 $14,520 $7,148 49.2%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 23 23 $6,900 $2,752 39.9%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 22 26 $4,030 $1,782 44.2%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2021 27 37 $2,405 $943.50 39.2%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 170 268 $29,480 $12,857 43.6%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 163 171 $29,925 $10,865 36.3%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 56 56 $17,920 $7,438 41.5%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 127 128 $14,080 $4,583 32.6%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 15 17 $2,635 $1,183 44.9%

About Benjamin Johnson

Benjamin Johnson is a Medical healthcare provider based in Utica, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2015. The National Provider Identifier (NPI) number assigned to this provider is 1518339951.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Benjamin Johnson has received a total of $8,880 in payments from pharmaceutical and medical device companies, with $1,469 received in 2024. These payments were reported across 282 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($5,171).

As a Medicare-enrolled provider, Johnson has provided services to 2,369 Medicare beneficiaries, totaling 2,820 services with total Medicare billing of $185,799. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.

Practice Information

  • Specialty Medical
  • Location Utica, NY
  • Active Since 10/26/2015
  • Last Updated 10/26/2015
  • Taxonomy Code 363AM0700X
  • Entity Type Individual
  • NPI Number 1518339951

Products in Payments

  • LINQ II (Device) $1,704
  • JARDIANCE (Drug) $718.58
  • ENTRESTO (Drug) $413.99
  • AZURE XT DR MRI SURESCAN (Device) $346.44
  • MICRA (Device) $317.38
  • XARELTO (Drug) $315.29
  • REVEAL LINQ (Device) $303.50
  • ELIQUIS (Drug) $260.12
  • Impella (Device) $200.26
  • VERQUVO (Drug) $192.30
  • Arcalyst (Drug) $159.90
  • Repatha (Biological) $159.50
  • LEQVIO (Drug) $152.55
  • Kerendia (Drug) $143.79
  • OPSUMIT (Drug) $112.97
  • VYNDAQEL (Drug) $76.77
  • CAMZYOS (Drug) $65.13
  • FARXIGA (Drug) $59.86
  • Azure (Device) $47.01
  • UPTRAVI (Drug) $40.85

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Medical Doctors in Utica